Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine in RSB vs QLB for Lower Abdominal Cancer Surgery
NCT06695468Phase 4Not yet recruiting
- Sponsor
- Assiut University
- Start
- Dec 2024
- Primary completion
- Dec 2026
- Modality
- Small Molecules
01
Overview
Phase 4, randomised trial of dexmedetomidine in postoperative pain (2 arms), sponsored by Assiut University. Primary endpoint: Pain intensity at 24 hours. Planned start Dec 2024; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06695468.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06695468.